Similar bacterial signatures in the gut microbiota of type 1 and type 2 diabetes patients and its association with G protein-coupled receptor 41 and 43 gene expression
Authors:
- 30 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (2) , 1359-1368
Abstract
Purpose There are conflicting reports regarding the abundance of short-chain fatty acids producing bacteria in the gut microbiota in patients with type 1 and type 2 diabetes. We aimed to determine the amount of Akkermansia muciniphila, Anaerobutyricum hallii, Bifidobacterium adolescentis, Bifidobacterium longum, Collinsella aerofaciens, Faecalibacterium prausnitzii, Lacticaseibacillus rhamnosus, and Parabacteroides distasonis in the gut microbiota in patients with type1 and type2 diabetes, compared with the healthy controls and analyze the correlation between the gene expression levels of two short-chain fatty acids receptors GPR41 and GPR43. Methods Forty type 1, 40 type 2 stool and blood samples of diabetes patients, and 40 healthy control samples were studied. DNA and RNA were extracted, and bacteria were detected using a Microbial DNA qPCR Assay kit. Gene expressions were detected with GPR41 and GPR43 primers via in-house qPCR. Results Compared with healthy controls, B.longum and F.prausnitzii abundance were significantly decreased in patients with type1 and type2 diabetes, A.hallii abundance was increased in patients with type1 and decreased in type2 diabetes contrarily A.muciniphila abundance was decreased in patients with type1 and increased in type2 diabetes. GPR43 gene expression was upregulated in both patients group, however GPR41 was upregulated only in patients with type2 diabetes. Conclusions Elevated B. longum and F. prausnitzii abundances were detected in the gut microbiota of patients with type1 and type2 diabetes and compared with healthy controls. B. longum and F.prausnitzii abundances were also correlated with the GPR43 gene expression level in type1 diabetes patients. Extensive studies determining bacteria producing short-chain fatty acids in gut microbiota, and their contribution in the pathogenesis of diabetes, are needed to understand better the mechanism of these diseases.Keywords
This publication has 38 references indexed in Scilit:
- Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspectivePostgraduate Medical Journal, 2015
- Enhanced butyrate formation by cross-feeding betweenFaecalibacterium prausnitziiandBifidobacterium adolescentisFEMS Microbiology Letters, 2015
- Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetesNature Medicine, 2015
- Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signalingJournal of Molecular Endocrinology, 2014
- Identification of the Porcine G Protein-Coupled Receptor 41 and 43 Genes and Their Expression Pattern in Different Tissues and Development StagesPLOS ONE, 2014
- Type 1 Diabetes and AutoimmunityClinical Pediatric Endocrinology, 2014
- GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric LeukocytesEndocrinology, 2013
- GPR43/FFA2: physiopathological relevance and therapeutic prospectsTrends in Pharmacological Sciences, 2013
- Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China populationFrontiers in Physiology, 2013
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001